Insider Selling: HealthEquity, Inc. (HQY) Director Sells $16,452,822.24 in Stock

HealthEquity, Inc. (NASDAQ:HQY) Director Frank Medici sold 316,644 shares of the company’s stock in a transaction on Monday, October 9th. The shares were sold at an average price of $51.96, for a total transaction of $16,452,822.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Frank Medici also recently made the following trade(s):

  • On Thursday, July 13th, Frank Medici sold 131,800 shares of HealthEquity stock. The shares were sold at an average price of $51.42, for a total transaction of $6,777,156.00.
  • On Wednesday, July 12th, Frank Medici sold 332,511 shares of HealthEquity stock. The shares were sold at an average price of $51.13, for a total transaction of $17,001,287.43.
  • On Friday, July 14th, Frank Medici sold 537,102 shares of HealthEquity stock. The shares were sold at an average price of $51.24, for a total transaction of $27,521,106.48.

Shares of HealthEquity, Inc. (HQY) opened at 51.39 on Friday. The firm has a market capitalization of $3.11 billion, a PE ratio of 76.25 and a beta of 1.80. HealthEquity, Inc. has a 12-month low of $30.34 and a 12-month high of $54.95. The company has a 50-day moving average of $46.90 and a 200 day moving average of $46.77.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, September 5th. The company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.13. The business had revenue of $56.90 million for the quarter, compared to the consensus estimate of $55.66 million. HealthEquity had a net margin of 20.27% and a return on equity of 13.93%. HealthEquity’s quarterly revenue was up 28.7% on a year-over-year basis. During the same quarter last year, the company posted $0.16 earnings per share. On average, analysts predict that HealthEquity, Inc. will post $0.71 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This story was first posted by Stock Observer and is the property of of Stock Observer. If you are reading this story on another site, it was illegally copied and reposted in violation of United States and international trademark & copyright legislation. The original version of this story can be accessed at https://www.thestockobserver.com/2017/10/13/insider-selling-healthequity-inc-hqy-director-sells-16452822-24-in-stock.html.

Several analysts recently issued reports on HQY shares. TheStreet raised shares of HealthEquity from a “c” rating to a “b” rating in a report on Monday, July 31st. Oppenheimer Holdings, Inc. reaffirmed a “buy” rating and issued a $61.00 price target on shares of HealthEquity in a report on Wednesday, September 6th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $56.00 price target on shares of HealthEquity in a report on Tuesday, September 5th. Zacks Investment Research raised shares of HealthEquity from a “hold” rating to a “buy” rating and set a $54.00 price target on the stock in a report on Wednesday, July 12th. Finally, Robert W. Baird reaffirmed a “hold” rating on shares of HealthEquity in a report on Thursday, September 21st. Two investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. HealthEquity presently has a consensus rating of “Buy” and a consensus price target of $57.17.

A number of hedge funds have recently modified their holdings of HQY. Fifth Third Bancorp lifted its position in HealthEquity by 382.8% in the first quarter. Fifth Third Bancorp now owns 2,414 shares of the company’s stock worth $102,000 after purchasing an additional 1,914 shares during the period. Oppenheimer Asset Management Inc. bought a new position in HealthEquity in the first quarter worth $106,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in HealthEquity by 105.8% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,544 shares of the company’s stock worth $127,000 after purchasing an additional 1,308 shares during the period. Riverhead Capital Management LLC lifted its position in HealthEquity by 75.3% in the second quarter. Riverhead Capital Management LLC now owns 2,629 shares of the company’s stock worth $131,000 after purchasing an additional 1,129 shares during the period. Finally, Exane Derivatives bought a new position in HealthEquity in the second quarter worth $132,000. 90.97% of the stock is owned by hedge funds and other institutional investors.

About HealthEquity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Insider Buying and Selling by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply